|Antimicrobial peptides: mechanism of action, activity and clinical potential|
QY Zhang, ZB Yan, YM Meng, XY Hong, G Shao, JJ Ma, XR Cheng, J Liu, ...
Military Medical Research 8 (1), 1-25, 2021
|The independence of and associations among apoptosis, autophagy, and necrosis|
Q Chen, J Kang, C Fu
Signal transduction and targeted therapy 3 (1), 1-11, 2018
|Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells|
J Kang, CM Sergio, RL Sutherland, EA Musgrove
BMC cancer 14 (1), 1-13, 2014
|Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells|
CE Caldon, CM Sergio, J Kang, A Muthukaruppan, MN Boersma, A Stone, ...
Molecular cancer therapeutics 11 (7), 1488-1499, 2012
|Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy|
J Kang, N Brajanovski, KT Chan, J Xuan, RB Pearson, E Sanij
Signal Transduction and Targeted Therapy 6 (1), 1-22, 2021
|Artemin is oncogenic for human mammary carcinoma cells|
J Kang, JK Perry, V Pandey, GC Fielder, B Mei, PX Qian, ZS Wu, T Zhu, ...
Oncogene 28 (19), 2034-2045, 2009
|Combination therapy targeting ribosome biogenesis and mRNA translation synergistically extends survival in MYC-driven lymphoma|
JR Devlin, KM Hannan, N Hein, C Cullinane, E Kusnadi, PY Ng, ...
Cancer discovery 6 (1), 59-70, 2016
|CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer|
E Sanij, KM Hannan, J Xuan, S Yan, JE Ahern, AS Trigos, N Brajanovski, ...
Nature communications 11 (1), 1-18, 2020
|Cystathionine β-synthase in physiology and cancer|
H Zhu, S Blake, KT Chan, RB Pearson, J Kang
BioMed research international 2018, 2018
|Regulation of rDNA transcription in response to growth factors, nutrients and energy|
EP Kusnadi, KM Hannan, RJ Hicks, RD Hannan, RB Pearson, J Kang
Gene 556 (1), 27-34, 2015
|Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma|
N Kannan, J Kang, X Kong, J Tang, JK Perry, KM Mohankumar, LD Miller, ...
Neoplasia 12 (12), 1041-IN31, 2010
|Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells|
V Pandey, PX Qian, J Kang, JK Perry, MD Mitchell, Z Yin, ZS Wu, DX Liu, ...
Endocrinology 151 (3), 909-920, 2010
|Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma|
J Kang, PX Qian, V Pandey, JK Perry, LD Miller, ET Liu, T Zhu, DX Liu, ...
Oncogene 29 (22), 3228-3240, 2010
|PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells|
Y Lu, TF Zhang, Y Shi, HW Zhou, Q Chen, BY Wei, X Wang, TX Yang, ...
Scientific reports 6 (1), 1-12, 2016
|Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload|
C Ge, H Huang, F Huang, T Yang, T Zhang, H Wu, H Zhou, Q Chen, Y Shi, ...
Proceedings of the National Academy of Sciences 116 (39), 19635-19645, 2019
|ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma|
A Banerjee, ZS Wu, PX Qian, J Kang, V Pandey, DX Liu, T Zhu, PE Lobie
Breast cancer research 13 (6), 1-20, 2011
|Oncogene-induced senescence: from biology to therapy|
H Zhu, S Blake, FK Kusuma, RB Pearson, J Kang, KT Chan
Mechanisms of ageing and development 187, 111229, 2020
|Artemin-stimulated progression of human non–small cell lung carcinoma is mediated by BCL2|
JZ Tang, XJ Kong, J Kang, GC Fielder, M Steiner, JK Perry, ZS Wu, Z Yin, ...
Molecular Cancer Therapeutics 9 (6), 1697-1708, 2010
|ARTEMIN Promotes De Novo Angiogenesis in ER Negative Mammary Carcinoma through Activation of TWIST1-VEGF-A Signalling|
A Banerjee, ZS Wu, PX Qian, J Kang, DX Liu, T Zhu, PE Lobie
PloS one 7 (11), e50098, 2012
|Artemin reduces sensitivity to doxorubicin and paclitaxel in endometrial carcinoma cells through specific regulation of CD24|
V Pandey, Y Jung, J Kang, M Steiner, PX Qian, A Banerjee, MD Mitchell, ...
Translational oncology 3 (4), 218-IN5, 2010